Cytokinetics, Incorporated (CYTK) Social Stream



Cytokinetics, Incorporated (CYTK): $56.41

0.50 (+0.89%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CYTK to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#242 of 340

in industry

CYTOKINETICS INC (CYTK) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CYTOKINETICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $75 $40 $53.444 $93.73 -42.98%
2021-12-01 9 $75 $40 $53.5 $93.73 -42.92%
2021-12-10 10 $75 $40 $53.909 $93.73 -42.48%
2021-12-21 10 $75 $40 $54.545 $93.73 -41.81%
2022-02-01 11 $75 $40 $54.666 $93.73 -41.68%
2022-02-15 11 $75 $40 $54.5 $93.73 -41.85%
2022-02-28 11 $75 $40 $54.166 $93.73 -42.21%
2022-03-02 11 $75 $40 $53.916 $93.73 -42.48%
2022-04-13 11 $75 $40 $54.272 $93.73 -42.1%
2022-04-29 11 $75 $40 $55.181 $93.73 -41.13%
2022-05-05 11 $75 $40 $56.727 $93.73 -39.48%
2022-05-16 11 $80 $40 $59.909 $93.73 -36.08%
2022-05-23 12 $80 $40 $60.916 $93.73 -35.01%
2022-05-26 12 $80 $40 $59.5 $93.73 -36.52%
2022-06-17 12 $80 $40 $61.333 $93.73 -34.56%
2022-08-05 10 $80 $54 $64.545 $93.73 -31.14%
2022-08-09 10 $80 $56 $65.636 $93.73 -29.97%
2022-08-12 10 $80 $15 $61.545 $93.73 -34.34%
2022-09-02 11 $80 $15 $62.727 $93.73 -33.08%
2022-10-03 11 $82 $15 $64.333 $93.73 -31.36%
2022-11-03 12 $82 $15 $65.538 $93.73 -30.08%
2022-11-20 12 $82 $57 $69 $93.73 -26.38%
2022-12-09 12 $82 $55 $68.307 $93.73 -27.12%
2022-12-14 12 $82 $55 $67.923 $93.73 -27.53%
2022-12-15 12 $82 $55 $66.461 $93.73 -29.09%
2022-12-20 14 $82 $55 $65 $93.73 -30.65%
2022-12-23 14 $82 $55 $64.857 $93.73 -30.8%
2023-02-14 14 $80 $47 $62.357 $93.73 -33.47%
2023-02-21 15 $80 $47 $61.466 $93.73 -34.42%
2023-03-01 15 $80 $47 $61.4 $93.73 -34.49%
2023-03-02 15 $80 $48 $61.533 $93.73 -34.35%
2023-03-06 15 $80 $48 $61.933 $93.73 -33.92%
2023-03-07 15 $80 $48 $61.933 $93.73 -33.92%
2023-03-20 15 $80 $48 $61.733 $93.73 -34.14%
2023-03-31 15 $80 $42 $61.2 $93.73 -34.71%
2023-04-03 15 $80 $42 $60.533 $93.73 -35.42%
2023-04-18 15 $80 $42 $60.2 $93.73 -35.77%
2023-05-05 15 $80 $41 $60.133 $93.73 -35.84%
2023-06-06 15 $80 $41 $60.533 $93.73 -35.42%
2023-08-07 16 $80 $41 $60.666 $93.73 -35.28%
2023-08-15 15 $80 $41 $60.5 $93.73 -35.45%
2023-10-09 14 $80 $41 $61 $93.73 -34.92%
2023-10-19 14 $80 $41 $61.4 $93.73 -34.49%
2023-10-20 14 $80 $41 $62 $93.73 -33.85%
2023-11-06 14 $80 $41 $61.6 $93.73 -34.28%
2023-11-07 15 $80 $41 $61.875 $93.73 -33.99%
2023-12-06 16 $80 $41 $61.176 $93.73 -34.73%
2023-12-22 15 $80 $41 $61.062 $93.73 -34.85%
2023-12-28 16 $107 $48 $73.352 $93.73 -21.74%

The Trend in the Analyst Price Target


Over the past 19 months, CYTK's average price target has gone up $13.85.

CYTK reports an average of 69.71% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-14 14 80 47 62.357 43.35 43.85%
2023-02-21 15 80 47 61.466 42.04 46.21%
2023-05-05 15 80 41 60.133 39.44 52.47%
2023-12-06 15 80 41 61.062 33.46 82.49%
2023-12-06 16 80 41 61.176 33.46 82.83%

CYTK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 13 2 1 0 0 16

The Trend in the Broker Recommendations


Over the past 23 months, CYTK's average broker recommendation rating improved by 0.02.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CYTK as an investment opportunity.

  • CYTOKINETICS INC's upside potential (average analyst target price relative to current price) is greater than 182.93% of all US stocks.
  • In terms of how CYTOKINETICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 5056.17% of that group.
  • CYTOKINETICS INC's average analyst price target is greater than 4440.97% of Pharmaceutical Products stocks.
  • In the context of stocks in the mid market cap category, CYTOKINETICS INC's variance in analysts' estimates is lower than -3944.73% of them.

In the Pharmaceutical Products industry, TGTX, MNKD, and LGND are the three stocks most similar to CYTOKINETICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CYTK using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!